GSK Trims Nutritional Drink Lines, Wants All Of Its Consumer JV Pie
This article was originally published in The Rose Sheet
Executive Summary
With its July 26 earnings report, the UK firm made clear it's ready to become sole owner of its consumer health JV with Novartis, and that divesting UK brands Horlicks and MaxiNutrition are among its steps toward cutting manufacturing costs.
You may also be interested in...
Merck, Pfizer Decorate Consumer Health 'For Sale' Signs With Strong Results
Merck KGAA reports 11% growth in sales of its OTC lines over a year ago, but, like Pfizer, looks to sharpen its long-term focus on the Rx business.
Merck, Pfizer Decorate Consumer Health 'For Sale' Signs With Strong Results
Merck KGAA reports 11% growth in sales of its OTC lines over a year ago, but, like Pfizer, looks to sharpen its long-term focus on the Rx business.
'For Sale' Signs In Consumer Health Sector As Firms Sharpen Pharma Focus
Freeing up spending for their Rx businesses prompt Merck KGAA to look at selling its division marketing Nasivin OTC nasal sprays, Omnibionta probiotic vitamins and other brands, and Pfizer to shop its consumer business with Advil analgesics, Centrum multivitamins and other OTC and dietary supplement brands.